Reversible cerebral vasoconstriction syndrome research hub

Calcium Channel blocker in treatment of reversible cerebral vasoconstriction syndrome: a double-blind, randomized, placebo-controlled trial.

This study looks at whether a common blood pressure medicine, amlodipine, can help people with a condition called Reversible Cerebral Vasoconstriction Syndrome (RCVS). They want to see if it reduces headaches and prevents problems like strokes. It's a late-stage study, comparing amlodipine to a dummy pill.